Your browser doesn't support javascript.
loading
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
Wang, Shuang-Jia; Sun, Bei; Cheng, Zhuo-Xin; Zhou, Hao-Xin; Gao, Yue; Kong, Rui; Chen, Hua; Jiang, Hong-Chi; Pan, Shang-Ha; Xue, Dong-Bo; Bai, Xue-Wei.
Affiliation
  • Wang SJ; Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People's Republic of China.
Cancer Chemother Pharmacol ; 68(6): 1421-30, 2011 Dec.
Article in En | MEDLINE | ID: mdl-21479633
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / NF-kappa B / Angiogenesis Inhibitors / Artemisinins / Neovascularization, Pathologic Limits: Animals / Humans / Male Language: En Journal: Cancer Chemother Pharmacol Year: 2011 Document type: Article Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / NF-kappa B / Angiogenesis Inhibitors / Artemisinins / Neovascularization, Pathologic Limits: Animals / Humans / Male Language: En Journal: Cancer Chemother Pharmacol Year: 2011 Document type: Article Country of publication: Alemania